Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology
Tate & Lyle and BioHarvest Sciences (NASDAQ: BHST) have announced a strategic partnership to develop next-generation plant-based ingredients for healthier food and beverages. The collaboration will initially focus on developing botanical sweetening ingredients using BioHarvest's proprietary Botanical Synthesis platform, which produces non-GMO plant-derived ingredients by growing targeted plant cells that mirror and magnify phyto-nutrients without traditional farming.
The partnership aims to create sugar-like sweeteners without aftertaste while using significantly less land and water compared to traditional methods. Tate & Lyle will contribute its sugar reduction expertise, regulatory knowledge, and global customer access, while BioHarvest brings its validated industrial-scale plant cell technology. The collaboration is part of Tate & Lyle's open innovation program to create cutting-edge solutions for the food and beverage industry.
Tate & Lyle e BioHarvest Sciences (NASDAQ: BHST) hanno annunciato una partnership strategica per sviluppare ingredienti vegetali di nuova generazione per alimenti e bevande più salutari. La collaborazione si concentrerà inizialmente sulla creazione di ingredienti dolcificanti botanici utilizzando la piattaforma di Sintesi Botanica proprietaria di BioHarvest, che produce ingredienti vegetali non OGM coltivando cellule vegetali mirate che imitano e amplificano i fito-nutrienti senza l'uso dell'agricoltura tradizionale.
La partnership mira a creare dolcificanti simili allo zucchero senza retrogusto, utilizzando significativamente meno terreno e acqua rispetto ai metodi tradizionali. Tate & Lyle porterà la sua esperienza nella riduzione dello zucchero, la conoscenza delle normative e l'accesso a clienti globali, mentre BioHarvest apporterà la sua tecnologia con cellule vegetali su scala industriale già convalidata. La collaborazione fa parte del programma di innovazione aperta di Tate & Lyle per creare soluzioni all'avanguardia per l'industria alimentare e delle bevande.
Tate & Lyle y BioHarvest Sciences (NASDAQ: BHST) han anunciado una asociación estratégica para desarrollar ingredientes vegetales de nueva generación para alimentos y bebidas más saludables. La colaboración se centrará inicialmente en el desarrollo de ingredientes endulzantes botánicos utilizando la plataforma de Síntesis Botánica de BioHarvest, que produce ingredientes derivados de plantas no OGM al cultivar células vegetales específicas que imitan y amplifican los fito-nutrientes sin la agricultura tradicional.
La asociación tiene como objetivo crear edulcorantes similares al azúcar sin regusto, utilizando significativamente menos tierra y agua en comparación con los métodos tradicionales. Tate & Lyle aportará su experiencia en la reducción del azúcar, conocimientos regulatorios y acceso a clientes globales, mientras que BioHarvest aportará su tecnología de células vegetales a escala industrial ya validada. La colaboración es parte del programa de innovación abierta de Tate & Lyle para crear soluciones innovadoras para la industria alimentaria y de bebidas.
테이트 & 라일과 바이오하베스트 사이언스 (NASDAQ: BHST)는 더 건강한 식품 및 음료를 위한 차세대 식물 기반 성분 개발을 위한 전략적 파트너십을 발표했습니다. 협력은 BioHarvest의 독점 식물 합성 플랫폼을 사용하여 식물 세포를 성장시켜 전통적인 농업 없이도 식물 유래 성분을 생산하는 데 처음으로 초점을 맞출 것입니다.
파트너십은 전통적인 방법에 비해 훨씬 적은 토지와 물을 사용하여 후미 맛이 없는 설탕과 유사한 감미료를 만드는 것을 목표로 합니다. 테이트 & 라일은 설탕 감소 전문 지식, 규제 지식 및 글로벌 고객 접근성을 제공하고, 바이오하베스트는 검증된 산업 규모 식물 세포 기술을 제공합니다. 이 협력은 식품 및 음료 산업을 위한 최첨단 솔루션을 만들기 위한 테이트 & 라일의 개방형 혁신 프로그램의 일환입니다.
Tate & Lyle et BioHarvest Sciences (NASDAQ: BHST) ont annoncé un partenariat stratégique pour développer des ingrédients d'origine végétale de nouvelle génération pour des aliments et des boissons plus sains. La collaboration se concentrera initialement sur le développement d'ingrédients sucrants botaniques en utilisant la plateforme de Synthèse Botanique propriétaire de BioHarvest, qui produit des ingrédients d'origine végétale non-OGM en cultivant des cellules végétales ciblées qui imitent et amplifient les phyto-nutriments sans agriculture traditionnelle.
Le partenariat vise à créer des édulcorants similaires au sucre sans arrière-goût tout en utilisant considérablement moins de terrain et d'eau par rapport aux méthodes traditionnelles. Tate & Lyle apportera son expertise en réduction de sucre, ses connaissances réglementaires et son accès à des clients mondiaux, tandis que BioHarvest mettra à disposition sa technologie validée de cellules végétales à l'échelle industrielle. La collaboration fait partie du programme d'innovation ouverte de Tate & Lyle pour créer des solutions de pointe pour l'industrie alimentaire et des boissons.
Tate & Lyle und BioHarvest Sciences (NASDAQ: BHST) haben eine strategische Partnerschaft angekündigt, um pflanzliche Inhaltsstoffe der nächsten Generation für gesündere Lebensmittel und Getränke zu entwickeln. Die Zusammenarbeit wird sich zunächst auf die Entwicklung von botanischen Süßungsmitteln konzentrieren, die die Botanical Synthesis Plattform von BioHarvest nutzen, die nicht-GVO-pflanzliche Inhaltsstoffe produziert, indem gezielte Pflanzenzellen gezüchtet werden, die Phyto-Nährstoffe ohne traditionelle Landwirtschaft nachahmen und verstärken.
Das Ziel der Partnerschaft ist es, zuckerähnliche Süßstoffe ohne Nachgeschmack zu schaffen und dabei erheblich weniger Land und Wasser im Vergleich zu traditionellen Methoden zu verwenden. Tate & Lyle wird sein Fachwissen in der Zuckerreduktion, regulatorisches Wissen und globalen Kundenzugang einbringen, während BioHarvest seine validierte Technologie für Pflanzenzellen im industriellen Maßstab bereitstellt. Die Zusammenarbeit ist Teil des Open-Innovation-Programms von Tate & Lyle, um bahnbrechende Lösungen für die Lebensmittel- und Getränkeindustrie zu entwickeln.
- Partnership with major industry player Tate & Lyle provides access to global markets and customers
- Technology enables more sustainable and economically viable production compared to traditional methods
- Potential for expanded applications beyond sweeteners in future developments
- Development timeline and costs for new sweeteners not specified
- No immediate revenue impact disclosed
- Success in commercial implementation remains uncertain
Insights
This strategic partnership marks a significant milestone for BioHarvest Sciences, potentially transforming its market position in the food ingredients industry. Tate & Lyle's global reach and established market presence could accelerate BioHarvest's commercialization timeline and market penetration. The focus on developing next-generation sweeteners addresses a
The partnership's initial focus on sweeteners targets a critical market need, as consumers increasingly seek healthier alternatives without compromising taste. Success in this venture could lead to expanded applications across other ingredient categories, multiplying the potential market opportunity.
BioHarvest's Botanical Synthesis technology represents a breakthrough in biotechnology manufacturing. The platform's ability to grow targeted plant cells and produce specific molecules without traditional agriculture addresses major industry challenges in scalability and sustainability. This process innovation could significantly reduce production costs and environmental impact compared to conventional extraction methods.
The partnership with Tate & Lyle adds important commercialization expertise and regulatory knowledge, essential for bringing these novel ingredients to market. The technology's potential to create patentable molecules provides strong intellectual property protection and could establish long-term competitive barriers. This collaboration could accelerate the development pipeline and reduce time-to-market for new ingredients.
New collaboration to pioneer next generation of plant-based ingredients for healthier food and beverages
London, United Kingdom and Vancouver, British Columbia--(Newsfile Corp. - December 11, 2024) - Tate & Lyle PLC ('Tate & Lyle'), a world leader in ingredient solutions for healthier and tastier food and beverages, and BioHarvest Sciences (NASDAQ: BHST) (CSE: BHSC) ('BioHarvest'), leaders in Botanical Synthesis, announce a pioneering new partnership to develop the next-generation of proprietary plant-based molecules to address increasing consumer desire for affordable, nutritious and more sustainable plant-derived food and beverage ingredients.
BioHarvest's proven Botanical Synthesis platform produces non-GMO plant-derived ingredients in a more sustainable and economically viable way, helping to scale up the production of highly beneficial botanical ingredients. This proprietary process delivers patentable molecules by growing targeted plant cells which can mirror and magnify the phyto-nutrients contained in specific plants, delivering all the benefits of the plant, without having to grow the plant.
The new partnership between Tate & Lyle and BioHarvest will focus on developing the next generation of sweeteners - botanical sweetening ingredients using plant-derived molecules. Along with the BioHarvest proprietary platform, this will meet consumer desire for a sugar-like taste - with no after-taste - and enable a wider population to have more choice when it comes to accessing healthier ingredients in products. The ingredient solutions will be more affordable to the food and beverage industry while using a fraction of the land and water required in traditional extraction and land-based growing practices.
Tate & Lyle brings its broad portfolio of sugar reduction solutions and years of ingredient research to the partnership, as well as its applications, nutrition and regulatory expertise, and access to global customers. The partnership forms part of Tate & Lyle's ongoing open innovation programme.
Nick Hampton, Chief Executive, Tate & Lyle commented:
"We are always looking to provide our customers with the latest innovation in the marketplace - this partnership with BioHarvest allows us to do just that. Our open innovation programme is all about creating cutting-edge solutions for the food and beverage industry. By partnering with entrepreneurial innovators like BioHarvest, we aim to disrupt the future of food for the better."
Victoria Spadaro-Grant, Tate & Lyle's Chief Science and Innovation Officer said:
"This partnership is very exciting for Tate & Lyle. BioHarvest provides the first and only fully validated industrial scale plant cell technology platform for production of plant metabolites. Initial exploration will focus on our sweetener platform, but our partnership also provides for expansion into other areas."
Ilan Sobel, CEO of BioHarvest Sciences said:
"We aspire to improve human wellness by availing our plant derived molecules to hundreds of millions of people and Tate & Lyle represents an ideal partner. Tate & Lyle is a global powerhouse in food ingredient innovation, and we expect that its regulatory and nutrition expertise, industry knowledge and complementary research initiatives will help expedite and commercialise the next generation of plant-based molecules developed through our Botanical Synthesis platform."
Dr Yochi Hagay, CTO and Co-Founder of BioHarvest Sciences added:
"This partnership forms a major milestone in the history of BioHarvest Sciences. It follows more than 15 years of intensive R&D and manufacturing scaling of our Botanical Synthesis technology process to the point that global innovators like Tate & Lyle can now leverage our capabilities to develop new plant-derived molecules to better meet consumer demand for healthier food and beverages."
About Tate & Lyle PLC:
Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.
Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.
Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 39 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet. Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2024, and on a pro forma basis which assumes for illustrative purposes that the combination with CP Kelco took place on 1 April 2023, revenue for the enlarged Tate & Lyle Group would have been £2.25 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube.
About BioHarvest Sciences Inc:
BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) is a leader in bioscience, leveraging its patented Botanical Synthesis technology platform to grow plant-based molecules, without the need to grow the underlying plant. BioHarvest is leveraging its Botanical Synthesis process technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance that new sweetener molecules will be commercialized, as any formulations will need to be tested for product suitability, which will include factors such as taste, after-taste, and affordability. All forward-looking statements are inherently uncertain, and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.
This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibilities for its contents.
For media enquiries, contact:
Maxine Boersma, Snr Manager, Global Corporate PR, Tate & Lyle PLC
Maxine.Boersma@tateandlyle.com +44(0) 7502 919579
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/233311
FAQ
What is the main focus of the Tate & Lyle and BHST partnership?
How does BHST's Botanical Synthesis technology work?
What advantages does the BHST partnership bring to sweetener production?
What role will Tate & Lyle play in the BHST partnership?
How will this partnership affect BHST's market reach?
